AAAAAA

   
Results: 1-9 |
Results: 9
PHASE-II STUDY OF CARBOXYAMIDO-TRIAZOLE (CAI) IN ANDROGEN-INDEPENDENTPROSTATE-CANCER (AIPC)
Authors: BAUER KS FIGG WD HAMILTON JM BERGAN R CHEN A DYER V WALTHER MM LINEHAN WM REED E
Citation: Ks. Bauer et al., PHASE-II STUDY OF CARBOXYAMIDO-TRIAZOLE (CAI) IN ANDROGEN-INDEPENDENTPROSTATE-CANCER (AIPC), Annals of oncology, 9, 1998, pp. 668-668
DO ALPRAZOLAM-INDUCED CHANGES IN SACCADIC EYE-MOVEMENT AND PSYCHOMOTOR FUNCTION FOLLOW THE SAME TIME-COURSE
Authors: KROBOTH PD FOLAN MM BAUER KS TULLOCK W WRIGHT EC SWEENEY JA
Citation: Pd. Kroboth et al., DO ALPRAZOLAM-INDUCED CHANGES IN SACCADIC EYE-MOVEMENT AND PSYCHOMOTOR FUNCTION FOLLOW THE SAME TIME-COURSE, Journal of clinical pharmacology, 38(4), 1998, pp. 337-346
INHIBITION OF ANGIOGENESIS BY THALIDOMIDE REQUIRES METABOLIC-ACTIVATION, WHICH IS SPECIES-DEPENDENT
Authors: BAUER KS DIXON SC FIGG WD
Citation: Ks. Bauer et al., INHIBITION OF ANGIOGENESIS BY THALIDOMIDE REQUIRES METABOLIC-ACTIVATION, WHICH IS SPECIES-DEPENDENT, Biochemical pharmacology, 55(11), 1998, pp. 1827-1834
MANAGEMENT OF HORMONE-SENSITIVE METASTATIC PROSTATE-CANCER - UPDATE ON HORMONAL-THERAPY
Authors: FIGG WD FEUER JA BAUER KS
Citation: Wd. Figg et al., MANAGEMENT OF HORMONE-SENSITIVE METASTATIC PROSTATE-CANCER - UPDATE ON HORMONAL-THERAPY, Cancer practice, 5(4), 1997, pp. 258-263
ADVERSE-EFFECTS OF RISPERIDONE ON EYE-MOVEMENT ACTIVITY - A COMPARISON OF RISPERIDONE AND HALOPERIDOL IN ANTIPSYCHOTIC-NAIVE SCHIZOPHRENIC-PATIENTS
Authors: SWEENEY JA BAUER KS KESHAVAN MS HAAS GL SCHOOLER NR KROBOTH PD
Citation: Ja. Sweeney et al., ADVERSE-EFFECTS OF RISPERIDONE ON EYE-MOVEMENT ACTIVITY - A COMPARISON OF RISPERIDONE AND HALOPERIDOL IN ANTIPSYCHOTIC-NAIVE SCHIZOPHRENIC-PATIENTS, Neuropsychopharmacology, 16(3), 1997, pp. 217-228
PHASE-I TRIAL OF MICRONIZED FORMULATION CARBOXYAMIDOTRIAZOLE IN PATIENTS WITH REFRACTORY SOLID TUMORS - PHARMACOKINETICS, CLINICAL OUTCOME,AND COMPARISON OF FORMULATIONS
Authors: KOHN EC FIGG WD SAROSY GA BAUER KS DAVIS PA SOLTIS MJ THOMPKINS A LIOTTA LA REED E
Citation: Ec. Kohn et al., PHASE-I TRIAL OF MICRONIZED FORMULATION CARBOXYAMIDOTRIAZOLE IN PATIENTS WITH REFRACTORY SOLID TUMORS - PHARMACOKINETICS, CLINICAL OUTCOME,AND COMPARISON OF FORMULATIONS, Journal of clinical oncology, 15(5), 1997, pp. 1985-1993
PHARMACOKINETICS (PK) OF MICRONIZED CARBOXY AMIDO-TRIAZOLE (CAI) IN CANCER-PATIENTS (PTS)
Authors: BAUER KS KOHN EC REED E SAROSY GA LUSH RM SIMMONS BR DAVIS PA FIGG WD
Citation: Ks. Bauer et al., PHARMACOKINETICS (PK) OF MICRONIZED CARBOXY AMIDO-TRIAZOLE (CAI) IN CANCER-PATIENTS (PTS), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 35-35
AN OPTIMIZED METHOD FOR THE QUANTITATION OF CARBOXYAMIDO-TRIAZOLE (CAI) IN HUMAN PLASMA WITH SOLID-PHASE EXTRACTION AND REVERSED-PHASE HPLC
Authors: SIMMONS BR BAUER KS MCCALL NA KOHN EC FIGG WD
Citation: Br. Simmons et al., AN OPTIMIZED METHOD FOR THE QUANTITATION OF CARBOXYAMIDO-TRIAZOLE (CAI) IN HUMAN PLASMA WITH SOLID-PHASE EXTRACTION AND REVERSED-PHASE HPLC, Analytical letters, 30(11), 1997, pp. 2009-2021
SACCADIC EYE-MOVEMENTS - USE IN A STUDY OF TOLERANCE TO ALPRAZOLAM (ALP)
Authors: KROBOTH PD SWEENEY JA BAUER KS COREY SE WRIGHT CE TULLOCK WC WATKINS WD FOLAN MM
Citation: Pd. Kroboth et al., SACCADIC EYE-MOVEMENTS - USE IN A STUDY OF TOLERANCE TO ALPRAZOLAM (ALP), Clinical pharmacology and therapeutics, 57(2), 1995, pp. 145-145
Risultati: 1-9 |